Upon testing the small molecule against five non-small cell lung cancer cell lines, we found that commercial N6,N6-dimethyladenosine recapitulated SN-A-024’s effect on AKT signaling, attenuating S473 phosphorylation in all cell types tested at both 10 and 1 micromolar concentrations (Figure 3B). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.